Reaction Details |
| Report a problem with these data |
Target | E3 ubiquitin-protein ligase Mdm2 |
---|
Ligand | BDBM31285 |
---|
Substrate/Competitor | Fl 9mer |
---|
Meas. Tech. | Fluorescent Peptide Displacement Assay |
---|
pH | 7.5±n/a |
---|
Temperature | 296.15±n/a K |
---|
IC50 | 420±n/a nM |
---|
Citation | Parks, DJ; LaFrance, LV; Calvo, RR; Milkiewicz, KL; Marugán, JJ; Raboisson, P; Schubert, C; Koblish, HK; Zhao, S; Franks, CF; Lattanze, J; Carver, TE; Cummings, MD; Maguire, D; Grasberger, BL; Maroney, AC; Lu, T Enhanced pharmacokinetic properties of 1,4-benzodiazepine-2,5-dione antagonists of the HDM2-p53 protein-protein interaction through structure-based drug design. Bioorg Med Chem Lett16:3310-4 (2006) [PubMed] Article |
---|
More Info.: | Get all data from this article, Solution Info, Assay Method |
---|
|
E3 ubiquitin-protein ligase Mdm2 |
---|
Name: | E3 ubiquitin-protein ligase Mdm2 |
Synonyms: | Double minute 2 protein | Double minute 2 protein (HDM2) | E3 ubiquitin-protein ligase Mdm2 (p53-binding protein Mdm2) | Hdm2 | Human Double Minute 2 (HDM2) | MDM2 | MDM2-MDMX | MDM2_HUMAN | p53-Binding Protein MDM2 | p53-binding protein |
Type: | Oncoprotein |
Mol. Mass.: | 55196.54 |
Organism: | Homo sapiens (Human) |
Description: | Q00987 |
Residue: | 491 |
Sequence: | MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQY
IMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGT
SVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQ
RKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDS
VSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLA
DYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVP
DCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQ
DKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQ
PIQMIVLTYFP
|
|
|
BDBM31285 |
---|
Fl 9mer |
---|
Name: | Fl 9mer |
Synonyms: | n/a |
Type: | fluorescent peptide |
Mol. Mass.: | 2263.48 |
Organism: | n/a |
Description: | n/a |
Residue: | 18 |
Sequence: | |